Diversity and Inclusion in Research Underpinning Prevention and Therapy Trials

Launched by ICAHN SCHOOL OF MEDICINE AT MOUNT SINAI · Dec 3, 2021

Keywords

ClinConnect Summary

The DISRUPT trial is a research project aimed at improving cancer care for people living in diverse and underserved communities in New York City. It focuses on breast, liver, and prostate cancers and seeks to reduce the differences in treatment and outcomes experienced by Black, Indigenous, and People of Color (BIPOC). The trial involves local organizations, healthcare providers, and scientists working together to create new ways of thinking about cancer research and treatment. This includes raising awareness in the community, helping patients find suitable clinical trials, and training healthcare professionals to understand the importance of diversity in medical research.

To participate in this trial, you need to be over 21 years old and diagnosed with invasive breast, lung, or liver cancer, facing a treatment decision. You also need to be able to give your consent and speak either English or Spanish. If you join, you can expect to engage with community health ambassadors who will provide information about cancer research and help you navigate your treatment options. This trial is currently recruiting participants and aims to change how cancer clinical trials are conducted to ensure all communities have better access to research and treatment options.

Gender

ALL

Eligibility criteria

• Inclusion Criteria:
• • All patients \>21 years of age with invasive breast, lung or liver cancer, who face a treatment decision
• • patients of doctors who have consented to participate
• • able to give consent and speak either English or Spanish
• • For provider recruitment, oncologists, and advanced practitioners caring for patients with breast, lung, liver cancer including medical and surgical oncologists, interventional radiologists \& hepatologists will be eligible
• Exclusion Criteria:
• • Patients who are unable to give consent
• • unable to understand English or Spanish
• • lack of invasive breast/liver cancer
• • those who do not face an imminent treatment decision